echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A&R: Therapeutic effects of cyclin-dependent kinase 4/6 inhibitors on skin fibrosis in a mouse model of systemic sclerosis

    A&R: Therapeutic effects of cyclin-dependent kinase 4/6 inhibitors on skin fibrosis in a mouse model of systemic sclerosis

    • Last Update: 2022-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Objective: One of the histological features of systemic sclerosis (SSc) is an increase in the number of dermal myofibroblasts, and transforming growth factor beta (TGF β ) plays a role in promoting the differentiation of fibroblasts into myofibroblasts and leading to dermal fibros.


    Objective: One of the histological features of systemic sclerosis (SSc) is an increase in the number of dermal myofibroblasts, and transforming growth factor beta (TGF β ) plays a role in promoting the differentiation of fibroblasts into myofibroblasts and leading to dermal fibros.


    Methods: Fibroblasts obtained from the skin of SSc patients were culturedin the presence or absence of TGF.


    Results: Addition of CDK4/6 inhibitors to cell cultures inhibited the proliferation of human dermal SSc fibroblasts and their TGFβ -induced myofibroblast differentiation, but not both canonical and non-canonical TGFβ signalin.


    Conclusions: The results of this study demonstrate the therapeutic efficacy of CDK4/6 inhibitors in skin fibrosis when used as monotherapy or in combination with TGFβR inhibitor.


    Source: Yamamoto,.


    Yamamoto,.
    , Saito,.
    , Hosoya,.
    , Kawahata,.
    , Asano,.
    , Sato,.
    , Mizoguchi,.
    , Yasuda,.
    and Kohsaka,.
    (2022), Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Scleros.
    Arthritis Rheumatol, 74: 860-87https://d.

    org/11002/a.

    42042Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.